We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$7.69B
AUM Growth
-$228M
Cap. Flow
-$66.9M
Cap. Flow %
-0.87%
Top 10 Hldgs %
18.39%
Holding
467
New
87
Increased
134
Reduced
143
Closed
77

Top Buys

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$69.7M
2
TDW icon
Tidewater
TDW
+$49.7M
3
ONTO icon
Onto Innovation
ONTO
+$45.1M
4
NE icon
Noble Corp
NE
+$45M
5
SNPS icon
Synopsys
SNPS
+$43.5M

Top Sells

Rank Stock Value
1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$94.7M
2
IRDM icon
Iridium Communications
IRDM
+$61.9M
3
INSP icon
Inspire Medical Systems
INSP
+$49M
4
WING icon
Wingstop
WING
+$47.9M
5
IBP icon
Installed Building Products
IBP
+$47.1M

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Industrials 20.08%
3 Healthcare 18.28%
4 Consumer Discretionary 9.44%
5 Consumer Staples 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRDN icon
451
Viridian Therapeutics
VRDN
$2.31B
– –
-84,019
Closed -$2M
WNS
452
DELISTED
WNS Holdings
WNS
– –
-234,073
Closed -$17.3M
YUM icon
453
Yum! Brands
YUM
$41.6B
– –
-2,766
Closed -$383K
FLG
454
Flagstar Bank National Association
FLG
$5.99B
– –
-3,380
Closed -$114K
ONC
455
BeOne Medicines Ltd
ONC
$34.1B
– –
-3,305
Closed -$589K
EDR
456
DELISTED
Endeavor Group Holdings, Inc.
EDR
– –
-319,538
Closed -$7.64M
RVNC
457
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-201,566
Closed -$5.1M
NAPA
458
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
– –
-590,313
Closed -$7.66M
MODN
459
DELISTED
MODEL N, INC.
MODN
– –
-234,609
Closed -$8.3M
SWAV
460
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-135,381
Closed -$38.6M
ESMT
461
DELISTED
EngageSmart, Inc.
ESMT
– –
-746,684
Closed -$14.3M
RETA
462
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-94,945
Closed -$9.68M
WWE
463
DELISTED
World Wrestling Entertainment
WWE
– –
-311,207
Closed -$33.8M
ZING
464
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
– –
-133,692
Closed -$1.39M
KDNY
465
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-107,053
Closed -$4.11M
DICE
466
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-2,038,257
Closed -$94.7M
ISEE
467
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-167,588
Closed -$6.59M
15 16 17 18
19

Similar funds

CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $13.5B AUM 15.15% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Driehaus Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Driehaus Capital Management held 467 positions worth $7.69B, down 2.9% from $7.92B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Driehaus Capital Management's Q3 2023 filing shows 87 new, 134 increased, 143 reduced and 77 closed positions. Its largest new stake was Camtek: 1,412,510 shares worth $87.9M. The largest sale was DICE Therapeutics, Inc. Common Stock, an estimated $94.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Driehaus Capital Management's largest Q3 2023 buy was Camtek: 1,412,510 shares worth $87.9M.
  • Driehaus Capital Management added most to Structure Therapeutics in Q3 2023, an estimated $40.4M increase.
  • Driehaus Capital Management's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $49M.
  • Driehaus Capital Management fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $94.7M.
  • Driehaus Capital Management's ten largest holdings make up 18% of its $7.69B portfolio in Q3 2023.
  • Driehaus Capital Management opened 87 new positions and closed 77 in Q3 2023.
  • Driehaus Capital Management's portfolio value fell 2.9% quarter-over-quarter to $7.69B.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.